212 related articles for article (PubMed ID: 21845358)
21. Comparison of malignant potential between serrated adenomas and traditional adenomas.
Song SY; Kim YH; Yu MK; Kim JH; Lee JM; Son HJ; Rhee PL; Kim JJ; Paik SW; Rhee JC
J Gastroenterol Hepatol; 2007 Nov; 22(11):1786-90. PubMed ID: 17914951
[TBL] [Abstract][Full Text] [Related]
22. Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.
Wang ZK; Liu J; Liu C; Wang FY; Chen CY; Zhang XH
J Gastroenterol Hepatol; 2012 Oct; 27(10):1629-34. PubMed ID: 22741528
[TBL] [Abstract][Full Text] [Related]
23. Role of the serrated pathway in colorectal cancer pathogenesis.
Leggett B; Whitehall V
Gastroenterology; 2010 Jun; 138(6):2088-100. PubMed ID: 20420948
[TBL] [Abstract][Full Text] [Related]
24. [Serrated lesions of colon and their malignant potential].
Wang LP; Chen J; Ning HY; Zhang XZ; Cheng J; Li L; Wang B; Dai XJ; Zhu HY; Miao JH; Wang L
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):447-51. PubMed ID: 21055172
[TBL] [Abstract][Full Text] [Related]
25. Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study.
Fujita K; Yamamoto H; Matsumoto T; Hirahashi M; Gushima M; Kishimoto J; Nishiyama K; Taguchi T; Yao T; Oda Y
Am J Surg Pathol; 2011 Feb; 35(2):295-304. PubMed ID: 21263251
[TBL] [Abstract][Full Text] [Related]
26. [Serrated precursor lesions].
Baretton GB; Aust DE
Pathologe; 2011 Nov; 32 Suppl 2():211-7. PubMed ID: 21915664
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma.
Bettington M; Walker N; Rosty C; Brown I; Clouston A; McKeone D; Pearson SA; Leggett B; Whitehall V
Gut; 2017 Jan; 66(1):97-106. PubMed ID: 26475632
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis.
Bossard C; Denis MG; Bézieau S; Bach-Ngohou K; Bourreille A; Laboisse CL; Mosnier JF
Oncol Rep; 2007 Nov; 18(5):1093-7. PubMed ID: 17914558
[TBL] [Abstract][Full Text] [Related]
29. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature.
Young J; Jass JR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1778-84. PubMed ID: 17035382
[TBL] [Abstract][Full Text] [Related]
30. Polyps as biomarkers for colorectal neoplasia.
Tobi M
Front Biosci; 1999 Mar; 4():D329-38. PubMed ID: 10077546
[TBL] [Abstract][Full Text] [Related]
31. Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
Miller GC; Liu C; Bettington ML; Leggett B; Whitehall VLJ; Rosty C
Hum Pathol; 2020 Mar; 97():19-28. PubMed ID: 31917154
[TBL] [Abstract][Full Text] [Related]
32. Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma.
Sekine S; Yamashita S; Tanabe T; Hashimoto T; Yoshida H; Taniguchi H; Kojima M; Shinmura K; Saito Y; Hiraoka N; Ushijima T; Ochiai A
J Pathol; 2016 Jun; 239(2):133-8. PubMed ID: 26924569
[TBL] [Abstract][Full Text] [Related]
33. Distribution of intestinal stem cell markers in colorectal precancerous lesions.
Jang BG; Kim HS; Kim KJ; Rhee YY; Kim WH; Kang GH
Histopathology; 2016 Mar; 68(4):567-77. PubMed ID: 26212207
[TBL] [Abstract][Full Text] [Related]
34. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.
García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P
Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730
[TBL] [Abstract][Full Text] [Related]
36. [Colorectal serrated lesions: current insight on their role in colorectal carcinogenesis].
Mäkinen M
Duodecim; 2010; 126(17):2002-11. PubMed ID: 21053517
[TBL] [Abstract][Full Text] [Related]
37. Revisiting the distinct histomorphologic features of inflammatory bowel disease-associated neoplastic precursor lesions in the SCENIC and post-DALM Era.
Gui X; Iacucci M; Ghosh S; Ferraz JGP; Lee S
Hum Pathol; 2020 Jun; 100():24-37. PubMed ID: 32387105
[TBL] [Abstract][Full Text] [Related]
38. [Small intestinal dysplasia, an unknown dysplasia].
Svrcek M; Fléjou JF
Ann Pathol; 2012 Nov; 32(5 Suppl):S58-62. PubMed ID: 23127942
[No Abstract] [Full Text] [Related]
39. Clonality assessment and clonal ordering of individual neoplastic crypts shows polyclonality of colorectal adenomas.
Thirlwell C; Will OC; Domingo E; Graham TA; McDonald SA; Oukrif D; Jeffrey R; Gorman M; Rodriguez-Justo M; Chin-Aleong J; Clark SK; Novelli MR; Jankowski JA; Wright NA; Tomlinson IP; Leedham SJ
Gastroenterology; 2010 Apr; 138(4):1441-54, 1454.e1-7. PubMed ID: 20102718
[TBL] [Abstract][Full Text] [Related]
40. Hyperplastic polyps and serrated adenomas: precancerous lesions with mixed immunophenotype.
Pap Z; Pávai Z; Dénes L; Brînzaniuc K; Jung I
Rom J Morphol Embryol; 2011; 52(3):797-802. PubMed ID: 21892521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
